Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial
The Lancet, 01/19/2012
Clinical Article
Buller HR et al. – Idrabiotaparinux could provide an attractive alternative to warfarin for the long–term treatment of pulmonary embolism, and seems to be associated with reduced bleeding.






